BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 20, 2004
View Archived Issues
First highly potent nonpeptide NK1 receptor agonist reported
Read More
Antiparkinsonian effects of adenosine A2A antagonist KF-17837 in animal models
Read More
Harvard Group to acquire assets of NexTherapeutics; IND anticipated for NXT-211
Read More
Assessment of response to melatonin replacement therapy in insomnia patients
Read More
Binodenoson reported better tolerated than adenosine in SPECT imaging
Read More
Increased cardiovascular risk found in subjects with metabolic syndrome
Read More
Interactions of NNRTIs GW-8248 and prodrug GW-5634 with HIV-1 RT investigated
Read More
Bayer BP and PPL sign termination and license agreement for recAAT program
Read More
Arexis acquires BSSL project from AstraZeneca
Read More
Purely Proteins and Abcam to develop protein/antibody tools for drug discovery
Read More
Enrollment under way in ORIGIN trial
Read More
Antiviral effects of TMC-114 and ritonavir in heavily pretreated HIV subjects
Read More
Effective prevention of perinatal HIV transmission with a nevirapine/zidovudine combination
Read More
New ER modulators presented by Ortho-McNeil researchers
Read More
Aventis describes NIK inhibitors and their use in inflammatory disorders
Read More
Novel antiangiogenic alphavbeta3 integrin inhibitor reported by Sigma-Tau
Read More
New NPY Y5 receptor antagonists in early development at Schering-Plough
Read More
Novel antiproliferative CDK inhibitors prepared and tested by Indian scientists
Read More
Vertex presents new inhibitors of JNK, Src, Lck and Aurora-2 kinase
Read More
New nicotinic receptor modulators emerged from Targacept R&D
Read More
Novel CCR3 antagonists for asthma therapy claimed by Roche
Read More
FemmePharma and Emory University to identify topical microbicides against HIV
Read More
MS-325 NDA accepted for filing
Read More
CX-516 mild cognitive impairment trial fails to meet primary endpoint
Read More
FDA approves Rhophylac
Read More
New TB vaccine enters clinical testing
Read More
Mid-year BLA filing planned for Antegren in MS
Read More
Poor phase III trials for Vanlev
Read More
Enrollment under way in phase III trial of Hyphanox
Read More
Nymox files PMA for AlzheimAlert test
Read More
Fast track status for ramoplanin in C. difficile-associated diarrhea
Read More
IND filing to study Modrenal for prostate cancer
Read More
Assessment of the efficacy and safety of ciclesonide during the 4th World Asthma Meeting
Read More
